Canine cases of Fusarium infection have rarely been reported [5], but there is a description of a Fusarium solani systemic infection [6].
Introduction
The Fusarium species are common soil saprophytes and plant pathogens and some have been reported as etiologic agents of opportunistic infections in humans [1] .
Several species of Fusarium have been described as the cause of human keratomycosis, mycetoma and onychomycosis, as well as disseminated infection in human patients with severe underlying diseases [1 -3] . Furthermore, steroid treatment, chemotherapy and underlying immunosuppressive diseases including acquired immunodefi ciency syndrome have been reported to facilitate subsequent Fusarium infections in humans [1, 3, 4] . ulceration (elbow to pad) on the left foreleg (Fig. 1a) but there was no fever. Hemat ology studies indicated slight anemia and serum bio chemical analysis showed no abnormal fi ndings except for high levels of alkaline phosphatase (ALP; 261 U/L). Urinalysis showed bilirubinuria, proteinuria (100 mg/dl) and polyuria (SG: 1.008). Hepatomegaly and spleno megaly were detected on the lateral view of a radiograph. High densities of the liver and spleen were observed at ultrasound examination. Histopathological examination of skin samples from the ulcerative lesion revealed numerous branching hyphae around neutrophils in the dermis (Fig. 1b) .
Since itraconazole (ITZ) is recommended for miscellaneous fungal infections [1], the dog was treated with ITZ at 20 mg/kg orally daily. However, the owner was not co operative in monitoring the case and the ulcerative lesions did not improved. The dog died due to renal failure 3 weeks after treatment. No autopsy was performed at the owner ' s request.
Mycological examination
Two biopsy specimens from deep tissues of the cutaneous lesion were cultured on Sabouraud ' s dextrose agar at 27 ° C for 2 weeks with fungal colonies developing within 1 week of inoculation.
Several hundred cells of the isolate recovered from the samples were lysed with 1 mg of zymolyase-100T (Seikagaku Corporation, Tokyo, Japan) in lysis buffer containing 0.1 mM EDTA, 1% sodium dodecyl sulfate (SDS), 10 mM Tris hydrochloride (pH 8.0) and 0.3% 2-mercaptoethanol, at 37 ° C for 16 h. High molecular weight DNA obtained from these samples by phenol and chloroform extraction were dissolved in TE buffer (10 mM Tris-hydrochloride, pH 8.0 and 1 mM EDTA) for polymerase chain reaction (PCR) amplifi cation.
The sequences of the primers for the ITS region were constructed based on previous reports [7] , i.e., forward primer ITS5 (5-GGA AGT AAA AGT CGT AAC AAG G) and reverse primer ITS4 (5-TCC TCC GCT TAT TGA TAT GC). The PCR products were sequenced by the dideoxy chain termination method using an ABI PRISM 310 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).
Results and discussion
The colony of the sub-cultured clinical isolate was fl at and white in color and had a cottony texture after 2-weeks incubation on Sabouraud ' s dextrose agar at 27 ° C (Fig. 2a) . There were numerous microconidia and macroconidia (Fig. 2b) . Microconidia were hyaline, oval, and nonseptated, measuring 10 -15 by 2 -5 μ m, while macroconidia were 40 -50 μ m long, hyaline, moderately curved, septated with generally three or more cells. Based on these fi ndings, the isolate was identifi ed as a Fusarium species [3] and the dog was diagnosed as having a Fusarium infection, possibly predisposed by the previous prednisone treatment.
Comparative sequence analyses with the ITS region in GenBank showed that the queried sequence of the clinical isolate was 100% identical to F. sporotrichioides (GenBank accession nos. FJ426386 and AF414972) and less than 96% similar to other Fusarium species. Therefore, the isolate was identifi ed as F. sporotrichioides by molecular analysis. The sequences reported in this paper have been deposited in the GenBank database [accession no. Fusarium sporotrichioides genes for 18S rRNA, Based on these fi ndings, the diagnosis of this canine case was refi ned to be F. sporotrichioides infection, which had not been previously reported in dogs and humans.
We treated an earlier canine case of systemic F. solani infection with ITZ at 5 mg/kg orally once a day combined with amphotericin B (AMB) at 0.15 mg/kg IV without success [6] . The prognosis of Fusarium infection in dogs might be regarded as poor.
Though the in vitro MIC of F. solani and Fusarium oxysporum against ITZ were 0.5 -Ͼ 16 μ g/ml [8] , the MIC values of F. sporotrichioides against this antifungal remains unknown. The combination therapy with AMB and ITZ was recommended to the dog ' s owner who refused the treatment in hospitalization. Therefore, ITZ at This paper was fi rst published online on Early Online on 27 October 2010.
